How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Giving AI actual write access in Revit. Can AI move past querying Revit models and start actually building inside them?

Forbes contributors publish independent expert analyses and insights. I cover the intersection of leadership, culture & equity in business. AI's greatest promise is saving time, not just boosting ...

See the TIOBE Index for September 2026, with Python still No. 1, Rust holding the top 10, and Julia nearing a return to the top 20. Rust held onto its place in the TIOBE Index top 10 in August 2026 ...

Bank fees can quietly add up, from monthly maintenance fees and overdraft charges to out-of-network ATM costs and even charges for paper statements. The good news is checking account fees actually ...

I’ve been reviewing laptops for well over a decade, sometimes testing more than 30 devices per year. They aren’t all winners, and many should be avoided, no matter how slick the marketing or cheap the ...

Michael Schmidt, CFA, is a staff member of FINRA's Dispute Resolution Board with 20+ years of experience in the financial market. Doretha Clemons, Ph.D., MBA, PMP, has been a corporate IT executive ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...